Literature DB >> 23448218

Epstein-Barr virus and multiple sclerosis: association or causation?

Julia Pakpoor1, Gavin Giovannoni, Sreeram V Ramagopalan.   

Abstract

Multiple sclerosis (MS) is a multifactorial disease in which both genetic and environmental factors and their interactions underlie causation. The current evidence base supports a strong association between Epstein-Barr virus (EBV) and MS, but potential causality remains strongly debated. It is not possible to exclude the possibility that an abnormal response to EBV infection is a consequence, rather than a cause, of the underlying pathophysiology of MS, or indeed that the association may be a reflection of a similar underlying disease mechanism. Substantial experimental progress is necessary to achieve consistency of molecular findings to complement the strong epidemiological association between EBV and MS, which cannot alone show causation. Collectively, the strength of the association between EBV and MS warrants careful development and trial of anti-EBV drugs to observe any effect on MS disease course.

Entities:  

Mesh:

Year:  2013        PMID: 23448218     DOI: 10.1586/ern.13.6

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  16 in total

Review 1.  Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.

Authors:  Ranjan Dutta
Journal:  Mult Scler       Date:  2013-09       Impact factor: 6.312

Review 2.  Evidence linking HHV-6 with multiple sclerosis: an update.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Curr Opin Virol       Date:  2014-10-17       Impact factor: 7.090

Review 3.  Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).

Authors:  Tina KhorshidAhmad; Crystal Acosta; Claudia Cortes; Ted M Lakowski; Surendiran Gangadaran; Michael Namaka
Journal:  Mol Neurobiol       Date:  2015-01-13       Impact factor: 5.590

Review 4.  Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus.

Authors:  Peter Hanlon; Alison Avenell; Lorna Aucott; Mark A Vickers
Journal:  Arthritis Res Ther       Date:  2014-01-06       Impact factor: 5.156

5.  Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis.

Authors:  Elisa Mazzoni; Silvia Pietrobon; Irene Masini; John Charles Rotondo; Mauro Gentile; Enrico Fainardi; Ilaria Casetta; Massimiliano Castellazzi; Enrico Granieri; Maria Luisa Caniati; Maria Rosaria Tola; Giovanni Guerra; Fernanda Martini; Mauro Tognon
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 6.  Epstein-Barr virus and its association with disease - a review of relevance to general practice.

Authors:  Anders Fugl; Christen Lykkegaard Andersen
Journal:  BMC Fam Pract       Date:  2019-05-14       Impact factor: 2.497

7.  Epstein-Barr virus-immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in xenograft mice.

Authors:  Pascal Polepole; Alison Bartenslager; Yutong Liu; Thomas M Petro; Samodha Fernando; Luwen Zhang
Journal:  J Med Virol       Date:  2020-10-05       Impact factor: 20.693

8.  Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?

Authors:  Giuseppe Mameli; Giordano Madeddu; Alessandra Mei; Elena Uleri; Luciana Poddighe; Lucia G Delogu; Ivana Maida; Sergio Babudieri; Caterina Serra; Roberto Manetti; Maria S Mura; Antonina Dolei
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

Review 9.  Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology.

Authors:  Jessica M Hogestyn; David J Mock; Margot Mayer-Proschel
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

10.  Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.

Authors:  Michael W Graner; Xiaoli Yu; Zhe Wang; Peter Ge Kennedy; Cecily Dupree; Min Wang; Catherin Lee; Tiffany Pointon; T Dianne Langford
Journal:  J Neuroimmune Pharmacol       Date:  2020-08-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.